• 1.

    Athavale A, et al. Desmopressin and bleeding risk after percutaneous kidney biopsy. BMC Nephrol 2019; 20:413. doi: 10.1186/s12882-019-1595-4.

  • 2.

    Manno C, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66:15701577.

  • 3.

    Peters B, et al. Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: a pilot study. Nephrology (Carlton) 2018; 23:366370.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Lim CC, et al. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia. Int Urol Nephrol 2019; 51:9951004.

  • 5.

    Moledina DG, et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol 2018; 13:16331640.

Desmopressin and Bleeding after Kidney Biopsy

Creatinine Level May Affect Risk

Tim O’Brien
Search for other papers by Tim O’Brien in
Current site
Google Scholar
Restricted access